Assessing Immunotherapy Efficacy in Syngeneic Models with Our NanoString Service

The PanCancer Immune Profiling and the PanCancer IO 360 panels are novel tools engineered specifically for syngeneic Immuno-Oncology studies.  With Canopy’s Immuno-Oncology service, researchers that were once limited  by sample type and low throughput technology  are now able to conduct high throughput robust analysis with a wide variety of  sample types including FFPE tissue.  Additionally, Canopy Biosciences provides a comprehensive data analysis package formatted for easy interpretation of immunotherapeutic efficacy data from your syngeneic study.

Canopy Biosciences Immuno-Oncology Offering:

• Does NOT require live cells
• Can conduct immune cell abundance scoring
• Uses minimal sample input (fresh or fixed tissue, cells, blood, serum, plasma, or PBMC’s)
• Can assess mechanistic pathway activity for single or combination studies
• Delivers a Comprehensive Data Analysis Package